Back to the main directory
EarningsReview / Equity
- Strong results and promising outlook by BNP Paribas
- What’s The Buyside Reading? Our Most Read US HPC & Beverage Research for February by BNP Paribas
- OMV and ADNOC agree Chemical’s merger - including Nova Chemicals by BNP Paribas
- Lerøy Seafood (Buy, TP: NOK67.00) - Q4 beat and good outlook by DnB Markets
- Medistim (Hold, TP: NOK172.00) - Higher sales and costs by DnB Markets
- Clas Ohlson (Buy, TP: SEK270.00) - 2024e EBIT margin set to exceed 10% by DnB Markets
- Rusta Minor model adjustments by DnB Markets
- UAE Food Retailers by HSBC
- Non material data changes by BNP Paribas
- 13th Consumer Ingredients & Chemicals Conference by BNP Paribas
- N.A. Tariffs; How it Affects Autos by BNP Paribas
- Lerøy Seafood - A strong starting point for 2025 by Danske Bank Equity Research
- Finally time to harvest by BNP Paribas
- FY24 results in-line with guidance; ’25 outlook slightly light, but targets reiterated and improving trajectory in sight by BNP Paribas
- Refocussing on cash generative top line growth by BNP Paribas
- Q4 in line, FY25 ahead, share buyback announced by BNP Paribas
- Analyst meeting feedback by BNP Paribas
- Valbiotis - FY24 by MidCap Partners
- INVEST SECURITIES - TOOSLA : CA 2024 rassurant, feuille de route 2024-27 confirmée - ACHAT, OC 2,6€ by Invest Securities
- INVEST SECURITIES - GRIFOLS : Un CMD convaincant, visibilité renforcée - ACHAT, OC 16€ vs 14€ by Invest Securities
- Q3’25 First Take: rental revenue softness, flat exit rate in Feb by BNP Paribas
- Origin Enterprises Plc - HY25 results above expectations by MidCap Partners
- doValue - MOMENTUM ON NPE FLOWS PROGRESSIVELY IMPROVING by Equita Sim
- Nexi - FCF SUSTAINABILITY TO SUPPORT REMUNERATION POLICY by Equita Sim
- Spin-off update by BNP Paribas
- FY 24 results post view by BNP Paribas
- Growth and forex are clear ST tailwinds, but fully priced in by BNP Paribas
- Diversified, after all by BNP Paribas
- Austevoll Seafood (Buy, TP: NOK131.00) - Lerøy stronger, stub softer by DnB Markets
- Tidewater (Buy, TP: USD62.00) - Growth set to pause in 2025 by DnB Markets
- Frontline Minor model adjustments by DnB Markets
- Seafood - Chilean biomass update by DnB Markets
- In the Flow by BNP Paribas
- Truworths (TRU SJ) by HSBC
- Restructuring detailed, with new LT target model by BNP Paribas
- February SAAR: Healthy Volumes Ahead of Tariffs by BNP Paribas
- FY24 results: negative share price reaction looks overdone by BNP Paribas
- FY24 results: margin slightly ahead, guidance unchanged by BNP Paribas
- VAT full FY24 First Take by BNP Paribas
- First take on H2 24 results: strong finish for the Defence topline by BNP Paribas
- Q4’24 First Take: 6% Adj. EBIT beat but disappointing ‘25e guidance at FCF level by BNP Paribas
- Cox Abg Group - 2H24 results: EBITDA beat, FY25 guidance supportive by JB Capital Markets
- Q4’24 First Take: 2024 in line. Robust long-term targets by BNP Paribas
- FY24 First Take: miss vs our expectations by BNP Paribas
- FY’24 First Take: mid-term margin upgrade and big buyback by BNP Paribas
- Origin Enterprises Plc - Résultats HY25 supérieurs aux attentes by MidCap Partners
- Valbiotis - FY24 by MidCap Partners
- STEEL US, TARIFFS, NUE by BNP Paribas
- Dell'Oro Q4 24 show RAN ex China returns to growth by BNP Paribas
- Strong margins, awaiting CMDs (+15 questions for management) by BNP Paribas